Jofra Tatiana, Galvani Giuseppe, Georgia Fousteri, Silvia Gregori, Gagliani Nicola, Battaglia Manuela
Diabetes Research Institute (DRI), IRCCS San Raffaele Scientific Institute, Milan, Italy.
San Raffaele Telethon Institute for Gene Therapy (SR-Tiget), IRCCS San Raffaele Scientific Institute, Milan, Italy.
Bio Protoc. 2018 Mar 5;8(5):e2743. doi: 10.21769/BioProtoc.2743.
Type 1 diabetes (T1D) is an autoimmune disease caused by the lack of insulin-producing pancreatic beta cells leading to systemic hyperglycemia. Pancreatic islet transplantation is a valid therapeutic approach to restore insulin loss and to promote adequate glycemic control. Pancreatic islet transplantation in mice is an optimal preclinical model to identify new therapeutic strategies aiming at preventing rejection and optimizing post-transplant immuno-suppressive/-tolerogenic therapies. Islet transplantation in preclinical animal models can be performed in different sites such the kidney capsule, spleen, bone marrow and pancreas. This protocol describes murine islet transplantation under the kidney capsule. This is a widely accepted procedure for research purposes. Stress caused in the animals is minimal and it leads to reliable and reproducible results.
1型糖尿病(T1D)是一种自身免疫性疾病,由缺乏产生胰岛素的胰腺β细胞导致全身性高血糖。胰岛移植是恢复胰岛素分泌并促进血糖充分控制的有效治疗方法。小鼠胰岛移植是一种理想的临床前模型,可用于确定旨在预防排斥反应和优化移植后免疫抑制/免疫耐受疗法的新治疗策略。临床前动物模型中的胰岛移植可在不同部位进行,如肾包膜、脾脏、骨髓和胰腺。本方案描述了肾包膜下的小鼠胰岛移植。这是一种广泛接受的用于研究目的的方法。动物所受压力最小,能产生可靠且可重复的结果。